Does RIPRETINIB Cause Pulmonary embolism? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Pulmonary embolism have been filed in association with RIPRETINIB (QINLOCK). This represents 0.3% of all adverse event reports for RIPRETINIB.
14
Reports of Pulmonary embolism with RIPRETINIB
0.3%
of all RIPRETINIB reports
9
Deaths
13
Hospitalizations
How Dangerous Is Pulmonary embolism From RIPRETINIB?
Of the 14 reports, 9 (64.3%) resulted in death, 13 (92.9%) required hospitalization, and 3 (21.4%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which RIPRETINIB Alternatives Have Lower Pulmonary embolism Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID